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Vaccination is considered to be most effective way of
fighting infectious diseases like malaria etc [1]. N, N,
N-trimethylchitosan (TMC) was synthesized from chito-
san. Nanoparticles of the TMC were prepared in various
media (milliQ water, Na2CO3 (pH 10.92), Na2HPO4 (pH
9.01) and alhydrogel
® beads which were characterized as
adjuvant for possible vaccine delivery. The nanoparticles
were analyzed using microscopy (Phase contrast micro-
scope and Confocal laser scanning microscope), and
Malvern zetasizer Nano- ZS. Time-resolved particle size
analysis was performed after one month storage of the
TMC nanoparticles at 4 °C. The result of the study
showed that PBS was the best medium that produced
cationic, monodispersed and stable TMC nanoparticles
of less than 65 nm forming a compatibly homogeneous
system even upon storage. Microscopy of the polyelec-
trolyte doped nanoparticles showed a clear coating due
to PSS at the periphery of the particles and a fluorescent
core with some tiny central hollow cavities Confocal
microscopy of the alhydrogel beads showed particle size
of 1.6 µm. The fluorescent dye (PSSRhodamine) coated
t h ee n t i r ep a r t i c l es u r f a c es u g g e s t i n gam o r eo rl e s s
adsorption process for the antigen delivery [2]. Hence,
the hope of nanocarrier for malaria vaccine.
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